Pfizer
Showing 1 - 25 of 6,074
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023
COVID-19 Respiratory Infection Trial in Sulaymaniyah (Vitamin-D)
Completed
- COVID-19 Respiratory Infection
- Vitamin-D
-
Sulaymaniyah, IraqHawal Lateef Fateh
May 10, 2023
COVID-19 Vaccines Using Information From California State
Not yet recruiting
- SARS-CoV-2
- +2 more
- Pfizer-BioNTech COVID-19 bivalent mRNA vaccine
- (no location specified)
May 23, 2023
Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study -
Recruiting
- COVID-19
- Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine
-
Pasadena, CaliforniaKaiser Permanente Southern California
Sep 21, 2022
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Ketamine, Morphine Trial in Kuala Lumpur (Ketamine-Morphine, Morphine)
Completed
- Ketamine
- Morphine
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUniversiti Kebangsaan Malaysia Medical Centre
Aug 27, 2023
Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,
Active, not recruiting
- Immunogenicity
- +2 more
- SW-BIC-213;SARS-Cov-2.
- +2 more
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Jan 8, 2023
Ketamine, Morphine Trial in Kuala Lumpur (Ketamine-Morphine, Morphine)
Completed
- Ketamine
- Morphine
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUniversiti Kebangsaan Malaysia Medical Centre
Aug 18, 2023
COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)
Active, not recruiting
- COVID-19
- Tozinameran - Standard dose
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Aug 24, 2022
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)
Not yet recruiting
- COVID-19
- Pfizer-BioNTech Standard dose
- +5 more
-
Bandung, West Java, Indonesia
- +2 more
Nov 30, 2022
COVID-19 Vaccines Trial in Paris (2nd booster with Comirnaty® (Pfizer-BioNTech), CoV2 preS dTM adjuvanted vaccine (B.1.351),
Active, not recruiting
- COVID-19 Vaccines
- 2nd booster with Comirnaty® (Pfizer-BioNTech)
- CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
Pneumococcal Disease, Invasive Trial in Denpasar (Walvax PCV13-TT, Pfizer PCV13)
Not yet recruiting
- Pneumococcal Disease, Invasive
- Walvax PCV13-TT
- Pfizer PCV13
-
Denpasar, Bali, IndonesiaDepartemen Ilmu Kesehatan Anak FK Unud
Jun 28, 2023
Safety and Efficacy of Trastuzumab BS
Not yet recruiting
- Gastric Cancer
- TRASTUZUMAB BS
- (no location specified)
Dec 19, 2022
Multiple Myeloma Trial in Montréal (Elranatamab)
Not yet recruiting
- Multiple Myeloma
-
Montréal, Quebec, CanadaMcGill University Health Centre
Sep 21, 2023
Cardiac Manifestation in Adolescent After Pfizer COVID-19
Completed
- Covid-19 Vaccine
- Diagnostic of ECG
-
BAngkok, ThailandFaculty of Tropical Medicine
May 29, 2022
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
COVID-19, Vaccine Reaction Trial in Paris (BNT162b2, CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK, CoV2 preS dTM
Active, not recruiting
- COVID-19
- Vaccine Reaction
- BNT162b2
- +2 more
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)
Recruiting
- Breast Cancer
- Head and Neck Cancer
- Palbociclib
- +3 more
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
- +3 more
Dec 14, 2022
COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)
Not yet recruiting
- COVID-19
- Tozinameran
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022
Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood
Not yet recruiting
- Fever After Vaccination
- +2 more
- Pfizer-BioNTech COVID-19 Vaccine
- Routine Childhood Vaccinations
-
Oakland, California
- +4 more
Sep 8, 2023
Hypertension Trial in Guangdong (Amlodipine besylate tablets (trade name: Norfloxacin ®), Amlodipine besylate controlled-release
Not yet recruiting
- Hypertension
- Amlodipine besylate tablets (trade name: Norfloxacin ®）
- Amlodipine besylate controlled-release tablets
-
Guangdong, Guangzhou, ChinaZhujiang Hospital of Southern Medical University
Jan 3, 2023
BESPONSA Injection 1 mg Special Investigation
Active, not recruiting
- Acute Lymphocytic Leukemia
-
Tokyo, JapanPfizer
Jun 20, 2023
Moderna COVID-19 Bivalent Booster for Omicron BA.4/5
Recruiting
- COVID-19
- Moderna COVID-19 Vaccine
- +3 more
-
Culver City, CaliforniaScience37
Mar 9, 2023